Evaluation of the Efficacy of an Innovative Digital Therapeutic Medical Device, Lyv Endo, for the Management of Patients With Endometriosis
Lyv Healthcare
304 participants
Jul 21, 2025
INTERVENTIONAL
Conditions
Summary
The main objective of this clinical study is to evaluate the clinical impact of using an innovative digital therapeutic device on the quality of life of patients with endometriosis. The working hypothesis is that the therapeutic digital medical device Lyv Endo may improve quality of life and reduce symptom intensity by enhancing patient engagement in the management of their condition. This justifies the need to evaluate the effect of Lyv Endo as a complement to standard medical care.
Eligibility
Inclusion Criteria6
- Women ≥18 years old
- with confirmed endometriosis diagnosis
- symptomatic patients (NRS ≥ 4 on one or more symptoms)
- French-speaking
- Owning a smartphone with internet/data,
- covered by French social security
Exclusion Criteria8
- Planned surgery during the study or surgery in the past 8 weeks
- Fertility hormone treatment during study
- Previous use of full Lyv Endo app or pilot program
- Pregnant or breastfeeding
- Under legal protection (guardianship, etc.)
- Cognitive or psychiatric conditions compromising consent
- Judged non-autonomous by investigator
- Participation in another interventional study
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Lyv Endo is a CE-marked Class I therapeutic digital medical device offering a patient-centered, integrative approach. Its innovation lies in its ability to deliver personalized content based on symptoms, surpassing the limits of traditional care.
Locations(6)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07175857